AMACR and Familial prostate cancer: Alpha-methylacyl-CoA racemase (AMACR) is routinely used as a biomarker in prostate cancer diagnosis as it is overexpressed in 80% [11] of prostate cancers at the protein and mRNA level [12, 13].